Companies / Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
CYTCIK 1662244
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 22, 2021 | Novo Holdings A/S 10% owner | Buy Open-market buy | COMMON STOCK | $5.00M | +278K +6.09% | 4,840,413 | high |
| Jun 22, 2021 | Droia Invest II SCSp 10% owner | Buy Open-market buy | Common Stock | $5.00M | +278K +8.52% | 3,536,803 | high |
| Jun 22, 2021 | Naesens Janwillem Director | Buy Open-market buy | Common Stock | $5.00M | +278K +8.52% | 3,536,803 | high |
| Jul 20, 2022 | Novo Holdings A/S 10% owner | Sell Open-market sale | COMMON STOCK | $2.70M | -900K -18.59% | 3,940,413 | medium |
| Jun 30, 2023 | Novo Holdings A/S 10% owner | Sell Open-market sale | Common Stock | $529.3K | -201K -5.20% | 3,662,636 | medium |
| Mar 20, 2024 | Leonard Braden Michael 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $503.2K | +171K +4.90% | 3,654,053 | high |
| Mar 18, 2024 | Leonard Braden Michael 10% owner | Buy Open-market buy | Common Stock, par value $0.001 per share | $342.5K | +114K +3.38% | 3,483,464 | medium |
| Jul 20, 2023 | Novo Holdings A/S 10% owner | Sell Open-market sale | Common Stock | $275.1K | -100K -2.76% | 3,522,136 | medium |